Acciones Easton Pharmaceuticals Inc. Other OTC
Acciones
EAPH
US2777741057
Biotecnología e investigación médica
Ventas 2019 | 1,56 M 1,45 M | Ventas 2020 | - | Capitalización | 807 mil 753 mil |
---|---|---|---|---|---|
Resultado Neto 2019 | - 0 | Resultado Neto 2020 | - 0 | VE / Ventas 2019 | 6,27 x |
Deuda neta 2019 | 8,41 M 7,85 M | Deuda neta 2020 | 2,48 M 2,32 M | VE / Ventas 2020 | - |
P/E ratio 2019 |
-4,17
x | P/E ratio 2020 |
-4,29
x | Empleados | - |
Rendimiento 2019 * |
-
| Rendimiento 2020 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/06/15 |
Vince Demasi
COO | Chief Operating Officer | - | 20/06/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/15 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/06/15 |
John Guerra
SEC | Corporate Secretary | - | 31/12/13 |
Vince Demasi
COO | Chief Operating Officer | - | 20/06/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,51 % | 122 mil M | |
+20,17 % | 115 mil M | |
+21,28 % | 26,64 mil M | |
-23,15 % | 19,91 mil M | |
-17,47 % | 16,32 mil M | |
-45,95 % | 15,52 mil M | |
-19,33 % | 15,49 mil M | |
+59,95 % | 14,83 mil M | |
+2,31 % | 13,67 mil M |